Free Trial

Globus Medical (GMED) Competitors

Globus Medical logo
$57.09 -0.71 (-1.23%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$57.10 +0.00 (+0.01%)
As of 07/11/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GMED vs. STE, PODD, BAX, HOLX, MASI, TFX, ITGR, ATEC, ATRC, and IART

Should you be buying Globus Medical stock or one of its competitors? The main competitors of Globus Medical include STERIS (STE), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Masimo (MASI), Teleflex (TFX), Integer (ITGR), Alphatec (ATEC), AtriCure (ATRC), and Integra LifeSciences (IART). These companies are all part of the "health care equipment" industry.

Globus Medical vs. Its Competitors

STERIS (NYSE:STE) and Globus Medical (NYSE:GMED) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, profitability, media sentiment, institutional ownership, risk, analyst recommendations, earnings and valuation.

In the previous week, STERIS had 2 more articles in the media than Globus Medical. MarketBeat recorded 11 mentions for STERIS and 9 mentions for Globus Medical. STERIS's average media sentiment score of 1.44 beat Globus Medical's score of 0.94 indicating that STERIS is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STERIS
11 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Globus Medical
5 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

94.7% of STERIS shares are held by institutional investors. Comparatively, 95.2% of Globus Medical shares are held by institutional investors. 1.1% of STERIS shares are held by company insiders. Comparatively, 18.5% of Globus Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

STERIS has a net margin of 11.26% compared to Globus Medical's net margin of 7.39%. STERIS's return on equity of 14.21% beat Globus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
STERIS11.26% 14.21% 9.13%
Globus Medical 7.39%10.52%8.56%

STERIS presently has a consensus price target of $263.83, indicating a potential upside of 15.76%. Globus Medical has a consensus price target of $94.00, indicating a potential upside of 64.65%. Given Globus Medical's higher possible upside, analysts plainly believe Globus Medical is more favorable than STERIS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STERIS
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.63
Globus Medical
0 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.62

STERIS has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Comparatively, Globus Medical has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500.

STERIS has higher revenue and earnings than Globus Medical. STERIS is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
STERIS$5.46B4.11$614.64M$6.2036.76
Globus Medical$2.52B3.07$102.98M$1.3442.60

Summary

STERIS beats Globus Medical on 10 of the 16 factors compared between the two stocks.

Get Globus Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMED and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GMED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GMED vs. The Competition

MetricGlobus MedicalMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$7.82B$6.82B$5.60B$20.78B
Dividend YieldN/A1.25%5.24%3.71%
P/E Ratio42.6024.8927.9627.89
Price / Sales3.0749.57429.7042.43
Price / Cash8.6820.9237.4622.63
Price / Book1.884.648.044.57
Net Income$102.98M$174.76M$3.18B$988.81M
7 Day Performance-3.40%-1.00%3.63%0.20%
1 Month Performance-5.07%-1.49%4.04%3.93%
1 Year Performance-19.67%4.27%29.56%10.27%

Globus Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GMED
Globus Medical
4.9445 of 5 stars
$57.09
-1.2%
$94.00
+64.7%
-19.3%$7.82B$2.52B42.605,300
STE
STERIS
4.7933 of 5 stars
$233.09
-1.9%
$263.83
+13.2%
+4.6%$23.37B$5.46B37.6017,787Positive News
PODD
Insulet
4.6021 of 5 stars
$300.70
-0.1%
$321.00
+6.8%
+42.1%$21.19B$2.07B54.083,900Positive News
Analyst Forecast
BAX
Baxter International
4.6272 of 5 stars
$29.70
-4.2%
$36.14
+21.7%
-18.5%$15.91B$10.64B-27.0038,000Analyst Forecast
HOLX
Hologic
4.7311 of 5 stars
$64.37
-0.6%
$77.42
+20.3%
-14.1%$14.44B$4.03B27.167,063Analyst Forecast
MASI
Masimo
4.0592 of 5 stars
$162.45
-3.1%
$191.60
+17.9%
+46.4%$9.09B$2.09B-17.725,600
TFX
Teleflex
4.7243 of 5 stars
$116.76
-2.6%
$164.63
+41.0%
-48.1%$5.30B$3.01B36.8314,100Positive News
ITGR
Integer
2.4599 of 5 stars
$117.05
-3.3%
$145.00
+23.9%
+2.1%$4.22B$1.72B55.4711,000News Coverage
ATEC
Alphatec
4.355 of 5 stars
$10.93
-0.5%
$17.89
+63.7%
+0.3%$1.61B$611.56M-9.50700Positive News
ATRC
AtriCure
3.1142 of 5 stars
$31.54
-0.7%
$50.67
+60.6%
+31.3%$1.57B$465.31M-38.941,300
IART
Integra LifeSciences
4.1546 of 5 stars
$12.75
-5.5%
$18.63
+46.1%
-58.9%$1.05B$1.61B-33.554,396

Related Companies and Tools


This page (NYSE:GMED) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners